Genetic Basis of Kidney Cancer: Role of Genomics for the Development of Disease-Based Therapeutics

Genome Research - United States
doi 10.1101/gr.131110.111
Full Text
Abstract

Available in full text

Categories
Genetics
Date
Authors
Publisher

Cold Spring Harbor Laboratory

Related search

Exploring the Genetic Basis of Early-Onset Chronic Kidney Disease

Nature Reviews Nephrology
Nephrology
2016English

The Use of Genomics to Drive Kidney Disease Drug Discovery and Development

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2020English

The Metabolic Basis of Kidney Cancer

Cancer Discovery
Oncology
2019English

Role of P-Glycoprotein Inhibitors in Ceramide-Based Therapeutics for Treatment of Cancer

Biochemical Pharmacology
BiochemistryPharmacology
2017English

The Role of Genomics in Studying Genetic Susceptibility to Infectious Disease: Figure 1.

Genome Research
Genetics
1997English

The Pharmacological Basis of Therapeutics.

Annals of Internal Medicine
Internal MedicineMedicine
1941English

The Development of Pro-Apoptotic Cancer Therapeutics

Mini-Reviews in Medicinal Chemistry
MedicineDrug DiscoveryPharmacology
2008English

Genomics and Therapeutics

Pathology
Forensic MedicinePathology
2020English

Uncovering Genetic Mechanisms of Kidney Aging Through Transcriptomics, Genomics, and Epigenomics

Kidney International
Nephrology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy